IRON

Disc Medicine, Inc.

32.19 USD
+0.01 (+0.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Disc Medicine, Inc. stock is up 7.23% since 30 days ago. The next earnings date is May 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Apr 19:13 21 Jun, 2024 30.00 PUT 619 8
08 Apr 19:49 21 Jun, 2024 30.00 PUT 250 8
09 Apr 14:09 19 Apr, 2024 40.00 PUT 44 184
09 Apr 15:38 19 Apr, 2024 35.00 PUT 71 1239
09 Apr 15:42 21 Jun, 2024 30.00 PUT 450 1257
16 Apr 19:22 21 Jun, 2024 35.00 CALL 234 25
19 Apr 14:57 17 May, 2024 40.00 PUT 23 11
19 Apr 14:58 17 May, 2024 40.00 PUT 30 11
19 Apr 15:12 17 May, 2024 40.00 PUT 65 11
25 Apr 16:03 21 Jun, 2024 25.00 CALL 100 1

About Disc Medicine, Inc.

Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.

  • HC Wainwright & Co.
    Fri May 10, 15:30
    buy
    confirm
  • Raymond James
    Fri May 10, 13:01
    buy
    confirm